Articles Archives
10/01/2025
Cryoport Systems Redefines the Global Supply Chain with Launch of New Facility Near Paris, France
Cryoport Systems is thrilled to announce the grand opening of our revolutionary Global Supply Chain Center in Louvre, France. This cutting-edge campus is a one-stop location for end-to-end, temperature-controlled supply chain solutions and is designed to tackle the most complex challenges in the life sciences industry.
09/10/2025
Scale Smarter: How Global Supply Chain Centers Amplify CGT Program Growth
Cell and gene therapy (CGT) programs are among the most complex and sensitive operations in the life sciences. From cryopreservation and biostorage to logistics and regulatory compliance, every step in the supply chain can influence product integrity, clinical timelines, and the scalability of the program. For program heads as well as clinical and technical operations teams, the challenge becomes bigger than merely moving materials. It quickly becomes a challenge of scaling efficiently while maintaining compliance and supporting growth across a global network.
08/20/2025
Protecting the Foundation of Biologics with Flexible, Scalable Cell Banking
For any biotherapeutic program, your cell bank is the foundation of your manufacturing process. Master cell banks (MCBs), working cell banks (WCBs), and research cell banks (RCBs), represent years of development work and intellectual property. They are irreplaceable assets, and the security of these assets is directly tied to the long-term success of your program.
07/25/2025
Scaling with Confidence for CDMO Supply Chain Alignment
Contract Development and Manufacturing Organizations (CDMOs) play a critical role in the life sciences industry, enabling biopharma innovators to bring new therapies from development to manufacturing to patients around the world. The demand placed on CDMOs has only increased in recent years, especially as cell, gene, and biologic therapies have moved from concept to clinic at unprecedented speeds. While the technical and scientific capabilities of CDMOs have advanced to meet these challenges, one area remains a frequent source of friction and delay...the end-to-end, temperature-controlled supply chain.
06/24/2025
When Every Hour Counts: How Cryoport Systems Rapidly Mobilized to Protect INmune Bio’s Critical Clinical Materials
Biopharmaceutical development, particularly for advanced CGTs, relies on a robust infrastructure of logistics, BioServices, and temperature-controlled supply chains to ensure timely and intact delivery of drug products under stringent regulations. INmune Bio Inc. faced a challenge when a sudden biostorage site closure jeopardized a key clinical trial. However, with a strong support network, they turned to established partners like Cryoport Systems to overcome the crisis.
06/23/2025
New in Contract Pharma: Enabling the Outcome Through End-to-End Supply Chain Excellence
Cryoport Systems is featured in Contract Pharma with an article discussing the benefits of a unified, end-to-end supply chain platform for advanced therapies. Titled "Enabling the Outcome: The Power of an End-to-End Supply Chain Platform for Advanced Therapies," the piece highlights the growing demand from advanced therapy sponsors, CDMOs, and clinical partners for integrated solutions that encompass logistics, BioServices, biostorage, and consulting in one partnership.
06/14/2025
Recognizing Donors and Advancing the Future of Cell Therapy
World Blood Donor Day serves as a reminder of the life-saving impact of voluntary blood and cell donations. These donations, often behind the scenes and not always recognized, are essential to emergency and surgical medicine and increasingly play an important role in cell and gene therapies. At Cryoport Systems, we recognize the incredible value of donors. We also understand that moving these donations safely, reliably, and under the strictest conditions, is a critical link between compassion and cure.
05/01/2025
New Article with Contract Pharma: Minimizing Capital Expenditures through Supply Chain Integration
Cryoport Systems has been featured in a new Contract Pharma article, “Minimizing Capital Expenditures through Supply Chain Integration.” This article explores how an integrated supply chain partner like Cryoport Systems helps organizations reduce risk, preserve capital, and gain the flexibility to scale without the burden of building it all themselves.
03/21/2025
